GH/IGF-1 axis is one of the main regulator of both bone modeling and remodeling. Therefore, GH deficient (GHD) patients have a derangment in these processes leading to impaired linear growth with delayed stature, reduced peak bone acquisition, reduced bone size, decrease in bone turnover, low bone mass, osteoporosis and increased fracture risk in adults. GH replacement therapy can restore a normal bone linear growth in children and can improve bone mass, reducing the fractures in GHD patients, whereas its application in treating osteoporosis in non-GHD patients is still controversial.

Osteoporosis in GH deficiency

Triggiani v
;
Guastamacchia e;
2019

Abstract

GH/IGF-1 axis is one of the main regulator of both bone modeling and remodeling. Therefore, GH deficient (GHD) patients have a derangment in these processes leading to impaired linear growth with delayed stature, reduced peak bone acquisition, reduced bone size, decrease in bone turnover, low bone mass, osteoporosis and increased fracture risk in adults. GH replacement therapy can restore a normal bone linear growth in children and can improve bone mass, reducing the fractures in GHD patients, whereas its application in treating osteoporosis in non-GHD patients is still controversial.
File in questo prodotto:
File Dimensione Formato  
Preprint GHD and osteoporosis Mancini EDs.pdf

non disponibili

Tipologia: Documento in Versione Editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.69 MB
Formato Adobe PDF
1.69 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11586/285775
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact